Ann: Antisense Therapeutics transitions to new Board Chair, page-100

I think Mark Diamond said :
"Upon completion of the manufacture of this batch of API by Avecia last month, the material was then shipped to Contract, Parenteral (injectable) Drug Product Manufacturer Pyramid Laboratories in Costa Messa, Southern California and formulated into injectable product for use in the Phase IIb trial. This formulated injectable product (Drug Product or DP) is currently undergoing finished product release testing for clinical use, with resultsanticipated later next month."

So, I believe Mark will make the announcement when the job is completed.

In fact not a bad idea to accumulate more at this current price level if you have faith in the ANP Management Team!...